No Data
No Data
Third Harmonic Bio's CSO Christopher Dinsmore Steps Down
Raymond James Maintains Third Harmonic Bio(THRD.US) With Hold Rating
Morgan Stanley Maintains Third Harmonic Bio(THRD.US) With Hold Rating, Raises Target Price to $5.23
Top 3 Health Care Stocks You May Want To Dump This Quarter
Here's Why We're Not Too Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Situation
Express News | Third Harmonic Bio Inc : Morgan Stanley Raises Target Price to $5.23 From $5.00